LEPU ScienTech Sets 21 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend

Bulletin Express

Aug 11

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. announced that its board of directors will convene on 21 August 2026. The agenda includes:

• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.

• Considering the publication of those results.

• Deliberating on the declaration of an interim dividend, if any.

The board is chaired by Executive Director Ms. Chen Juan. Non-executive directors are Ms. Zhang Yuxin, Mr. Fu Shan and Mr. Zhu Guanfu, while independent non-executive directors include Ms. Chan Ka Lai Vanessa, Mr. Zheng Yufeng and Mr. Zheng Junwei.

The notice underscores the company’s standard governance practice of formally approving financial statements and dividend proposals at a scheduled board session before public disclosure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1156034935"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156034935\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156034935?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156034935","market":"us","top_or_hot":-1,"title":"LEPU ScienTech Sets 21 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend","media":"Bulletin Express","content":"<p>LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. announced that its board of directors will convene on 21 August 2026. The agenda includes:</p>\n<p>• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.</p>\n<p>• Considering the publication of those results.</p>\n<p>• Deliberating on the declaration of an interim dividend, if any.</p>\n<p>The board is chaired by Executive Director Ms. Chen Juan. Non-executive directors are Ms. Zhang Yuxin, Mr. Fu Shan and Mr. Zhu Guanfu, while independent non-executive directors include Ms. Chan Ka Lai Vanessa, Mr. Zheng Yufeng and Mr. Zheng Junwei.</p>\n<p>The notice underscores the company’s standard governance practice of formally approving financial statements and dividend proposals at a scheduled board session before public disclosure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEPU ScienTech Sets 21 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEPU ScienTech Sets 21 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-11 18:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. announced that its board of directors will convene on 21 August 2026. The agenda includes:</p>\n<p>• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.</p>\n<p>• Considering the publication of those results.</p>\n<p>• Deliberating on the declaration of an interim dividend, if any.</p>\n<p>The board is chaired by Executive Director Ms. Chen Juan. Non-executive directors are Ms. Zhang Yuxin, Mr. Fu Shan and Mr. Zhu Guanfu, while independent non-executive directors include Ms. Chan Ka Lai Vanessa, Mr. Zheng Yufeng and Mr. Zheng Junwei.</p>\n<p>The notice underscores the company’s standard governance practice of formally approving financial statements and dividend proposals at a scheduled board session before public disclosure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02291","symbol_name":"心泰医疗","start_time":0,"source_url":"","article_id":"1156034935","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156034935","pubTimestamp":1786443806,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. announced that its board of directors will convene on 21 August 2026. The agenda includes: • Reviewing and approving the consolidated interim...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02291":"心泰医疗"},"translate_title":"乐普科技定于 2026 年 8 月 21 日召开董事会会议，审查 2026 年上半年业绩和潜在中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02291":1},"content_text":"LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. announced that its board of directors will convene on 21 August 2026. The agenda includes:\n• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.\n• Considering the publication of those results.\n• Deliberating on the declaration of an interim dividend, if any.\nThe board is chaired by Executive Director Ms. Chen Juan. Non-executive directors are Ms. Zhang Yuxin, Mr. Fu Shan and Mr. Zhu Guanfu, while independent non-executive directors include Ms. Chan Ka Lai Vanessa, Mr. Zheng Yufeng and Mr. Zheng Junwei.\nThe notice underscores the company’s standard governance practice of formally approving financial statements and dividend proposals at a scheduled board session before public disclosure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}